Publications:

Whole-exome sequencing of cervical carcinomas identifies activating ERBB2 and PIK3CA mutations as targets for combination therapy.

Proceedings Of The National Academy Of Sciences Of The United States Of America

Zammataro, Luca L; Lopez, Salvatore S; Bellone, Stefania S; Pettinella, Francesca F; Bonazzoli, Elena E; Perrone, Emanuele E; Zhao, Siming S; Menderes, Gulden G; Altwerger, Gary G; Han, Chanhee C; Zeybek, Burak B; Bianchi, Anna A; Manzano, Aranzazu A; Manara, Paola P; Cocco, Emiliano E; Buza, Natalia N; Hui, Pei P; Wong, Serena S; Ravaggi, Antonella A; Bignotti, Eliana E; Romani, Chiara C; Todeschini, Paola P; Zanotti, Laura L; Odicino, Franco F; Pecorelli, Sergio S; Donzelli, Carla C; Ardighieri, Laura L; Angioli, Roberto R; Raspagliesi, Francesco F; Scambia, Giovanni G; Choi, Jungmin J; Dong, Weilai W; Bilguvar, Kaya K; Alexandrov, Ludmil B LB; Silasi, Dan-Arin DA; Huang, Gloria S GS; Ratner, Elena E; Azodi, Masoud M; Schwartz, Peter E PE; Pirazzoli, Valentina V; Stiegler, Amy L AL; Boggon, Titus J TJ; Lifton, Richard P RP; Schlessinger, Joseph J; Santin, Alessandro D AD

Publication Date: 2019-11-05

Variant appearance in text: SI: S216F

PubMed Link: 31624127

Variant Present in the following documents:

• Main text

View BVdb publication page